Literature DB >> 28244812

Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.

Susanne B Haga1, Rachel Mills1, Jivan Moaddeb1, Nancy Allen LaPointe2, Alex Cho3, Geoffrey S Ginsburg1.   

Abstract

AIM: To investigate provider utilization of pharmacist support in the delivery of pharmacogenetic testing in a primary care setting.
METHODS: Two primary care clinics within Duke University Health System participated in the study between December 2012 and July 2013. One clinic was provided with an in-house pharmacist and the second clinic had an on-call pharmacist.
RESULTS: Providers in the in-house pharmacist arm consulted with the pharmacist for 13 of 15 cases, or about one of every four patients tested compared with one of every 7.5 patients in the on-call pharmacist arm. A total of 63 tests were ordered, 48 by providers in the pharmacist-in-house arm.
CONCLUSION: These findings suggest that the availability of an in-house pharmacist increases the likelihood of pharmacogenetic test utilization.

Entities:  

Keywords:  delivery model; education; pharmacist consultation; pharmacogenetic testing

Mesh:

Year:  2017        PMID: 28244812      PMCID: PMC5558524          DOI: 10.2217/pgs-2016-0177

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  40 in total

1.  Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008.

Authors:  Qiuping Gu; Charles F Dillon; Vicki L Burt
Journal:  NCHS Data Brief       Date:  2010-09

Review 2.  The role of computerized decision support in reducing errors in selecting medicines for prescription: narrative review.

Authors:  Melissa T Baysari; Johanna Westbrook; Jeffrey Braithwaite; Richard O Day
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

Review 3.  Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients.

Authors:  Wendy L St Peter; T Michael Farley; Barry L Carter
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-09       Impact factor: 2.894

4.  Patient experiences with pharmacogenetic testing in a primary care setting.

Authors:  Susanne B Haga; Rachel Mills; Jivan Moaddeb; Nancy Allen Lapointe; Alex Cho; Geoffrey S Ginsburg
Journal:  Pharmacogenomics       Date:  2016-09-20       Impact factor: 2.533

5.  Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.

Authors:  Brian J Isetts; Daniel E Buffington; Barry L Carter; Marie Smith; Linnea A Polgreen; Paul A James
Journal:  Pharmacotherapy       Date:  2016-03-18       Impact factor: 4.705

6.  Pharmacist-physician collaboration improves blood pressure control.

Authors:  Abla M Albsoul-Younes; Eman A Hammad; Nada A Yasein; Linda M Tahaineh
Journal:  Saudi Med J       Date:  2011-03       Impact factor: 1.484

7.  Primary care physicians' knowledge of and experience with pharmacogenetic testing.

Authors:  S B Haga; W Burke; G S Ginsburg; R Mills; R Agans
Journal:  Clin Genet       Date:  2012-07-03       Impact factor: 4.438

8.  Description of pharmacist interventions during physician-pharmacist co-management of hypertension.

Authors:  Shannon J Von Muenster; Barry L Carter; Cynthia A Weber; Michael E Ernst; Jessica L Milchak; Jennifer J G Steffensmeier; Yinghui Xu
Journal:  Pharm World Sci       Date:  2007-08-21

9.  A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy.

Authors:  J T Hanlon; M Weinberger; G P Samsa; K E Schmader; K M Uttech; I K Lewis; P A Cowper; P B Landsman; H J Cohen; J R Feussner
Journal:  Am J Med       Date:  1996-04       Impact factor: 4.965

10.  Effectiveness of oncogenetics training on general practitioners' consultation skills: a randomized controlled trial.

Authors:  Elisa J F Houwink; Arno M M Muijtjens; Sarah R van Teeffelen; Lidewij Henneman; Jan Joost Rethans; Liesbeth E J van der Jagt; Scheltus J van Luijk; Geert Jan Dinant; Cees van der Vleuten; Martina C Cornel
Journal:  Genet Med       Date:  2013-05-30       Impact factor: 8.822

View more
  9 in total

1.  Implementation and obstacles of pharmacogenetics in clinical practice: An international survey.

Authors:  Elizabeth Abou Diwan; Ralph I Zeitoun; Lea Abou Haidar; Ingolf Cascorbi; Nathalie Khoueiry Zgheib
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

2.  Impact of SLCO1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review.

Authors:  Jason L Vassy; Sojeong Chun; Sanjay Advani; Sophie A Ludin; Jason G Smith; Elaine C Alligood
Journal:  Clin Pharmacol Ther       Date:  2018-10-18       Impact factor: 6.875

Review 3.  The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review.

Authors:  Nick Dragojlovic; Kennedy Borle; Nicola Kopac; Ursula Ellis; Patricia Birch; Shelin Adam; Jan M Friedman; Amy Nisselle; Alison M Elliott; Larry D Lynd
Journal:  Genet Med       Date:  2020-06-24       Impact factor: 8.822

4.  Approaches to assessing the provider experience with clinical pharmacogenomic information: a scoping review.

Authors:  Nicholas J Keeling; Tyler J Dunn; John P Bentley; Sujith Ramachandran; James M Hoffman; Meagen Rosenthal
Journal:  Genet Med       Date:  2021-04-29       Impact factor: 8.822

5.  The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand.

Authors:  Simran D S Maggo; Kyra L V Sycamore; Allison L Miller; Martin A Kennedy
Journal:  Front Psychiatry       Date:  2019-09-20       Impact factor: 4.157

Review 6.  Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.

Authors:  Judith Hayward; John McDermott; Nadeem Qureshi; William Newman
Journal:  Pharmacogenomics       Date:  2021-09-01       Impact factor: 2.533

7.  Public perceptions of pharmacogenomic services in Ireland - Are people with chronic disease more likely to want service availability than those without? A questionnaire study.

Authors:  Joseph O'Shea; Cristín Ryan; Joseph Gallagher; Claire O'Brien; Conor Morris; Eoin Dwyer; James Mc Laughlin; Laura Fitzpatrick; Maire O'Meara; Sarah Kelly; Sophie Knox; Mark Ledwidge
Journal:  Explor Res Clin Soc Pharm       Date:  2022-09-21

8.  Multi-Institutional Implementation of Clinical Decision Support for APOL1, NAT2, and YEATS4 Genotyping in Antihypertensive Management.

Authors:  Thomas M Schneider; Michael T Eadon; Rhonda M Cooper-DeHoff; Kerri L Cavanaugh; Khoa A Nguyen; Meghan J Arwood; Emma M Tillman; Victoria M Pratt; Paul R Dexter; Allison B McCoy; Lori A Orlando; Stuart A Scott; Girish N Nadkarni; Carol R Horowitz; Joseph L Kannry
Journal:  J Pers Med       Date:  2021-05-27

9.  Current landscape of personalized medicine adoption and implementation in Southeast Asia.

Authors:  Huey Yi Chong; Pascale A Allotey; Nathorn Chaiyakunapruk
Journal:  BMC Med Genomics       Date:  2018-10-26       Impact factor: 3.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.